Another study reported that the level of ADIPOQ in serum is lower in NAFLD than controls and was associated with increased liver enzymes and lipid profile changes in patients with NAFLD [74]. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.